Loading the content... Loading depends on your connection speed!

Shopping Cart - $0.00

Musculoskeletal Drugs Market Global Briefing 2017

Musculoskeletal Drugs Market Global Briefing 2017

From $1,000.00

Including: Drugs For Rheumatoid Arthritis, Muscle Relaxants, Others.
Covering: F. Hoffmann-La Roche Ltd., GlaxosmithKline Plc., Pfizer Inc., Daiichi Sankyo Company, Limited, Abbott Laboratories Inc., Johnson & Johnson, Sanofi S.A., Novartis AG, Otsuka Pharmaceutical Co., Ltd., Celgene Corporation


Clear selection
SKU: 2277. Categories: , .
Description

Drugs for Rheumatoid Arthritis was the largest segment in the musculoskeletal drugs market accounting for around 24% of the market. This can be attributed to the high prevalence of rheumatoid arthritis around the world that requires medicines to control disease progression. Muscle Relaxants was the second largest segment in the musculoskeletal drugs market accounting for around 14% of the market. Others segment accounted for over 60% in the musculoskeletal drugs market.

Musculoskeletal Drugs Market Global Briefing from the Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.

The market characteristics section of the report defines and explains the market.

The market size section gives the musculoskeletal drugs market revenues, covering both the historic growth of the market and forecasting the future.

Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.

The trends and strategies section highlights the likely future developments in the musculoskeletal drugs market and suggests approaches.

Reasons to Purchase

• Get up to date information available on the musculoskeletal drugs market globally.
• Identify growth segments and opportunities.
• Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
• Develop strategies based on likely future developments.
• Gain a global perspective on the development of the market.

 

Scope

Markets Covered: Drugs For Rheumatoid Arthritis, Muscle Relaxants, Others.
Companies Mentioned: F. Hoffmann-La Roche Ltd., GlaxosmithKline Plc., Pfizer Inc., Daiichi Sankyo Company Limited, Abbott Laboratories Inc., Johnson & Johnson, Sanofi S.A., Novartis AG, Otsuka Pharmaceutical Co., Ltd., Celgene Corporation
Geographic scope: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Market value in $ billions.
Data segmentations: Regional breakdowns, market share of competitors, key sub segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Executive Summary
The musculoskeletal system drugs market comprises companies that discover, develop, manufacture and distribute medications used in the treatment of musculoskeletal diseases. Musculoskeletal diseases include arthritis, osteoporosis, osteomalacia, carpal tunnel syndrome, tendonitis, rotator cuff tear, muscular dystrophy, myasthenia gravis, lupus erythematosus and others. Some of the major drugs in the market include Piroxicam Glaxo, Dolonex, Felden, and Piroxicam Pfizer.

The global musculoskeletal drugs market is expected toreach over $165 billion in 2020. This can be attributed to the expected increase in healthcare awareness, number of surgical operations and prevalence of musculoskeletal disorders such as fibromyalgia, rheumatoid arthritis, osteoarthritis around the world. Also, increasing number of road accidents and workplace injuries are expected to contribute to market growth.

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) For Acute Musculoskeletal Pain - Topical NSAIDs are being used for treatment of acute musculoskeletal pain in adults. A NSAID penetrates the skin, enter tissues or joints, and reduce processes causing pain in the tissue. It can be used as a gel, cream, spray, or plaster to unbroken skin with musculoskeletal pain. Topical NSAIDs also leads to very low level of drug in the blood as compared to oral drugs, thus, minimizing the risk of harmful effects. In June 2015, medical research organization Cochrane published the results of its clinical trials to compare topical NSAIDs with placebo or other medicines in patients above 16 years with musculoskeletal pain. These results indicate that gel formulations of NSAIDs diclofenac and ketoprofen were more effective in treatment of strain, sprain, or muscle pull, as compared to placebo.
Table of Contents
Musculoskeletal Drugs Market Characteristics 4
Musculoskeletal Drugs Market Historic Growth 5
Musculoskeletal Drugs Market Forecast Growth 6
Musculoskeletal Drugs Market Segmentation 8
Global Musculoskeletal Drugs Market, Split By Segments, 2016, $ Billion 8
Drugs for Rheumatoid Arthritis 9
Muscle Relaxants 9
Others 9
Global Musculoskeletal Drugs Market, Historic and Forecast, Split By Segments, 2012-2020 10
Musculoskeletal Drugs Market Geography Regional and Country Comparison 12
Global Musculoskeletal Drugs Market, Split By Regions, 2016 12
Global Musculoskeletal Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2012-2020 14
Global Musculoskeletal Drugs Market, Split By Country, 2016 16
Global Musculoskeletal Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2012-2020 18
Musculoskeletal Drugs Market Competitive Landscape 20
F. Hoffmann-La Roche Ltd. 21
Pfizer Inc. 21
GlaxosmithKline Plc. 21
Daiichi Sankyo Company, Limited 21
Abbott Laboratories Inc. 21
Johnson & Johnson 21
Sanofi S.A. 21
Novartis AG 21
Otsuka Pharmaceutical Co., Ltd. 21
Celgene Corporation 21
F.Hoffmann-La Roche 22
GlaxoSmithKline 22
Pfizer 23
Musculoskeletal Drugs Market Key Mergers And Acquisitions 24
AbbVie Acquired Pharmacyclics 24
Valeant Acquired Salix Pharmaceuticals 24
Roche Acquired Adheron Therapeutics 24
Musculoskeletal Drugs Market Trends And Strategies 25
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) For Acute Musculoskeletal Pain 25
New Drug Delivery Technologies 25
Use of Muscle Relaxants in New Indications 25
Appendix 26
NAICS Definitions Of Industry Covered In This Report 26
Definition Of Market Covered In This Report 26
Abbreviations 26
Currencies 27
Research Methodology 27
Research Inquiries 28
The Business Research Company 28

List of Figures
Figure 1: Global Musculoskeletal Drugs Market, Historic Market Size, 2012-2016, $ Billion 5
Figure 2: Global Musculoskeletal Drugs Market, Forecast Market Size, 2016 – 2020, $ Billion 6
Figure 3: Global Musculoskeletal Drugs Market, Split By Segments, 2016, $ Billion 8
Figure 4: Global Musculoskeletal Drugs Market, Historic and Forecast, Split By Segment, 2012 – 2020 10
Figure 5: Global Musculoskeletal Drugs Market, Split By Region, 2016, $ Billion 12
Figure 6: Global Musculoskeletal Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2012-2020 14
Figure 7: Global Musculoskeletal Drugs Market, Split By Country, 2016, $ Billion 16
Figure 8: Global Musculoskeletal Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2012-2020 18
Figure 9: Global Musculoskeletal Drugs Market, Key Competitor Market Shares, 2016, Percentage (%) 20

List of Tables
Table 1: Global Musculoskeletal Drugs Market, Historic Market Size, 2012-2016, $ Billion 5
Table 2: Global Musculoskeletal Drugs Market, Forecast Market Size, 2016 – 2020, $ Billion 6
Table 3: Global Musculoskeletal Drugs Market, Split By Segments, 2016, $ Billion 8
Table 4: Global Musculoskeletal Drugs Market, Historic and Forecast, Split By Segment, 2012 – 2020 10
Table 5: Global Musculoskeletal Drugs Market, Split By Region, 2016, $ Billion 13
Table 6: Global Musculoskeletal Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2012-2020 14
Table 7: Global Musculoskeletal Drugs Market, Split By Country, 2016, $ Billion 16
Table 8: Global Musculoskeletal Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2012-2020 18
Table 9: Global Musculoskeletal Drugs Market, Key Competitor Market Shares, 2016, Percentage (%) 21
Get Customized Report
Please fill in your details. Our team will get back to you